Advances in the Diagnosis and Treatment of Cervical Cancer - Episode 5
Clinical insights on treatment options for patients with newly diagnosed metastatic cervical cancer, with a focus on immunotherapy and the KEYNOTE-826 trial.
Related Content:
FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors
Crafting an Individual Treatment Plan for Patients With Prostate Cancer
Commitment to Patients Is Driven by a Lasting Promise
Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care